| Remdesivir: review of pharmacology, pre‐clinical data, and emerging clinical experience for COVID‐19 SCJ Jorgensen, R Kebriaei, LD Dresser Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 40 (7 …, 2020 | 267 | 2020 |
| Evaluation of the synergy of ceftazidime-avibactam in combination with meropenem, amikacin, aztreonam, colistin, or fosfomycin against well-characterized multidrug-resistant … S Mikhail, NB Singh, R Kebriaei, SA Rice, KC Stamper, M Castanheira, ... Antimicrobial agents and chemotherapy 63 (8), 10.1128/aac. 00779-19, 2019 | 117 | 2019 |
| Bacteriophage therapeutics: a primer for clinicians on phage‐antibiotic combinations T Morrisette, R Kebriaei, KL Lev, S Morales, MJ Rybak Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 40 (2 …, 2020 | 81 | 2020 |
| Evaluation of eravacycline: a novel fluorocycline S Alosaimy, JC Abdul‐Mutakabbir, R Kebriaei, SCJ Jorgensen, MJ Rybak Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 40 (3 …, 2020 | 47 | 2020 |
| Cefiderocol: a novel Siderophore cephalosporin against multidrug‐resistant gram‐negative pathogens JC Abdul‐Mutakabbir, S Alosaimy, T Morrisette, R Kebriaei, MJ Rybak Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 40 (12 …, 2020 | 43 | 2020 |
| Bacteriophage-antibiotic combination strategy: an alternative against methicillin-resistant phenotypes of Staphylococcus aureus R Kebriaei, K Lev, T Morrisette, KC Stamper, JC Abdul-Mutakabbir, ... Antimicrobial agents and chemotherapy 64 (7), 10.1128/aac. 00461-20, 2020 | 41 | 2020 |
| In Vitro Antibacterial Activity of Cefiderocol against Multidrug-Resistant Acinetobacter baumannii JC Abdul-Mutakabbir, L Nguyen, PT Maassen, KC Stamper, R Kebriaei, ... Antimicrobial agents and chemotherapy 65 (9), 10.1128/aac. 02646-20, 2021 | 37 | 2021 |
| Influence of inoculum effect on the efficacy of daptomycin monotherapy and in combination with β-lactams against daptomycin-susceptible Enterococcus faecium harboring LiaSR … R Kebriaei, SA Rice, KV Singh, KC Stamper, AQ Dinh, R Rios, L Diaz, ... Antimicrobial Agents and Chemotherapy 62 (8), 10.1128/aac. 00315-18, 2018 | 37 | 2018 |
| Bacteriophage-antibiotic combinations for Enterococcus faecium with varying bacteriophage and daptomycin susceptibilities T Morrisette, KL Lev, R Kebriaei, JC Abdul-Mutakabbir, KC Stamper, ... Antimicrobial agents and chemotherapy 64 (9), 10.1128/aac. 00993-20, 2020 | 32 | 2020 |
| Teaching an Old Class New Tricks: A Novel Semi-Synthetic Aminoglycoside, Plazomicin MJR Jacinda C. Abdul-Mutakabbir, Razieh Kebriaei, Sarah C. J. Jorgensen Infectious Diseases and Therapy, pp 1-16, 2019 | 29* | 2019 |
| Impact of Daptomycin Dose Exposure Alone or in Combination with β-Lactams or Rifampin against Vancomycin-Resistant Enterococci in an In Vitro Biofilm Model S Jahanbakhsh, NB Singh, J Yim, R Kebriaei, JR Smith, K Lev, TT Tran, ... Antimicrobial agents and chemotherapy 64 (5), 10.1128/aac. 02074-19, 2020 | 28 | 2020 |
| Evaluation of dalbavancin alone and in combination with β-lactam antibiotics against resistant phenotypes of Staphylococcus aureus X Xhemali, JR Smith, R Kebriaei, SA Rice, KC Stamper, M Compton, ... Journal of Antimicrobial Chemotherapy 74 (1), 82-86, 2019 | 25 | 2019 |
| Combination of Vancomycin and Cefazolin Lipid Nanoparticles for Overcoming Antibiotic Resistance of MRSA K Bhise, S Sau, R Kebriaei, SA Rice, KC Stamper, HO Alsaab, MJ Rybak, ... Materials 11 (7), 2018 | 25 | 2018 |
| The combination of tedizolid and daptomycin against methicillin-resistant Staphylococcus aureus in an in vitro model of simulated endocardial vegetations. RKMJR Jordan R. Smith, Juwon Yim, Seth Rice, Kyle Stamper Antimicrob Agents Chemother 62 (4), 2018 | 25 | 2018 |
| The evolving reduction of vancomycin and daptomycin susceptibility in MRSA—salvaging the gold standards with combination therapy T Morrisette, S Alosaimy, JC Abdul-Mutakabbir, R Kebriaei, MJ Rybak Antibiotics 9 (11), 762, 2020 | 24 | 2020 |
| Dalbavancin Alone and in Combination with Ceftaroline against Four Different Phenotypes of Staphylococcus aureus in a Simulated Pharmacodynamic … R Kebriaei, SA Rice, KC Stamper, MJ Rybak Antimicrobial Agents and Chemotherapy 63 (4), 10.1128/aac. 01743-18, 2019 | 24 | 2019 |
| Eradication of Biofilm-Mediated Methicillin-Resistant Staphylococcus aureus Infections In Vitro: Bacteriophage-Antibiotic Combination R Kebriaei, KL Lev, RM Shah, KC Stamper, DJ Holger, T Morrisette, ... Microbiology Spectrum 10 (2), e00411-22, 2022 | 23 | 2022 |
| In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant Acinetobacter baumannii JC Abdul-Mutakabbir, J Yim, L Nguyen, PT Maassen, K Stamper, ... Antibiotics 10 (7), 880, 2021 | 22 | 2021 |
| Clinical Pharmacology of Bacteriophage Therapy: A Focus on Multidrug-Resistant Pseudomonas aeruginosa Infections D Holger, R Kebriaei, T Morrisette, K Lev, J Alexander, M Rybak Antibiotics 10 (5), 556, 2021 | 19 | 2021 |
| Bacteriophage‐antibiotic combination therapy for multidrug‐resistant Pseudomonas aeruginosa: In vitro synergy testing DJ Holger, KL Lev, R Kebriaei, T Morrisette, R Shah, J Alexander, ... Journal of Applied Microbiology 133 (3), 1636-1649, 2022 | 15 | 2022 |
Michael J. Rybak, Pharm.D., M.P.H., P...Wayne State University在 wayne.edu 的电子邮件经过验证
